Anadys Pharmaceuticals to Announce First Quarter 2004 Financial Results on May 13, 2004.Business Editors SAN DIEGO--(BUSINESS WIRE)--May 6, 2004 Anadys Pharmaceuticals, Inc. (Nasdaq:ANDS), a biopharmaceutical company committed to the discovery, development and commercialization of novel therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. to treat hepatitis C Hepatitis C Definition Hepatitis C is a form of liver inflammation that causes primarily a long-lasting (chronic) disease. Acute (newly developed) hepatitis C is rarely observed as the early disease is generally quite mild. , hepatitis B Hepatitis B Definition Hepatitis B is a potentially serious form of liver inflammation due to infection by the hepatitis B virus (HBV). It occurs in both rapidly developing (acute) and long-lasting (chronic) forms, and is one of the most common chronic and bacterial bacterial /bac·te·ri·al/ (-al) pertaining to or caused by bacteria. bacterial pertaining to or caused by bacteria. bacterial adhesiveness see adhesins. infections, today announced that it will report first quarter 2004 financial results on Thursday, May 13, 2004 after the U.S. financial markets close. Anadys will hold a conference call and webcast to discuss the first quarter results and provide an update on the company's progress towards future goals on Thursday, May 13, 2004, at 4:30 p.m. ET. To access the webcast via the internet, log on to http://ir.anadyspharma.com. Alternatively, please call 1-800-901-5213 (U.S.) or 1-617-786-2962 (international) and dial the participant passcode 35481348 to access the call. Telephone replay is available through May 20, 2004. To access, please call 1-888-286-8010 (U.S.) or 1-617-801-6888 (international) and dial the participant passcode 94909363. The webcast will be archived on http://ir.anadyspharma.com through May 31, 2004. Anadys Pharmaceuticals, Inc. (www.anadyspharma.com) is a biopharmaceutical company committed to advancing patient care by discovering, developing and commercializing novel small molecule, anti-infective an·ti-in·fec·tive adj. Capable of preventing or counteracting infection. n. An anti-infective agent or drug. anti-infective 1. counteracting infection. 2. a substance that counteracts infection. medicines for the treatment of hepatitis C virus
|
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion